Oncology November 2012
Current Screening, Prevention, and Treatment Guidelines for Lung Cancer
Lung cancer is the second leading cause of cancer in the United States.
Novel Target Therapy and Immunotherapy for Skin Cancer
Over a 12-month period, the FDA unprecedentedly approved several new drugs for the treatment of skin cancer.
Continuing Education
$7.95 Per CE Exam or $69 for 12 Lessons
-
• April 2026 • 2.00 Credits
Managing HIV Coinfections and Complications
-
Pain Management • March 2026 • 2.00 Credits
Updated Guidance for Opioid Use in Pain Management
-
Cardiovascular • February 2026 • 2.00 Credits
Managing Modifiable Risk Factors in Chronic Coronary Disease
Copyright © 2000 - 2024 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.